The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer
Prostate Cancer and Prostatic Diseases advance online publication, May 9 2017.
doi:10.1038/pcan.2017.29
Authors: L Tosco, A Laenen, A Briganti, P Gontero, R J Karnes, M Albersen, P J Bastian, P Chlosta, F Claessens, F K Chun, W Everaerts, C Gratzke, M Graefen, B Kneitz, G Marchioro, R S Salas, B Tombal, T Van den Broeck, L Moris, A Battaglia, H van der Poel, J Walz, A Bossi, G De Meerleer, K Haustermans, H Van Poppel, M Spahn & S Joniau
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: L Tosco A Laenen A Briganti P Gontero R J Karnes M Albersen P J Bastian P Chlosta F Claessens F K Chun W Everaerts C Gratzke M Graefen B Kneitz G Marchioro R S Salas B Tombal T Van den Broeck L Moris A Battaglia H van der Poel J Walz A Bossi G De Meerleer Source Type: research
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Neoadjuvant Therapy | Prostate Cancer